Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach
Non-Operative Therapy Of Local-Regional Carcinoma Of The Esophagus: A Randomizd Phase II Study Of Two Paclitaxel-Based Chemoradiotherapy Regimens
2 other identifiers
interventional
N/A
1 country
66
Brief Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy and radiation therapy may kill more tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of combination chemotherapy plus radiation therapy with and without fluorouracil in treating patients who have cancer of the esophagus or stomach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
66 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2001
CompletedStudy Start
First participant enrolled
April 1, 2001
CompletedFirst Posted
Study publicly available on registry
January 27, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2006
CompletedJuly 19, 2013
July 1, 2004
5.3 years
February 2, 2001
July 17, 2013
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Radiation Therapy Oncology Grouplead
- National Cancer Institute (NCI)collaborator
Study Sites (66)
Mobile Infirmary Medical Center
Mobile, Alabama, 36652-2144, United States
Foundation for Cancer Research and Education
Phoenix, Arizona, 85013, United States
City of Hope Comprehensive Cancer Center
Duarte, California, 91010-3000, United States
Leavey Cancer Center at Northridge Hospital Medical Center
Northridge, California, 91328, United States
University of Florida Shands Cancer Center
Gainesville, Florida, 32610-0385, United States
Baptist-South Miami Regional Cancer Program
Miami, Florida, 33176-2197, United States
CCOP - Mount Sinai Medical Center
Miami Beach, Florida, 33140, United States
Cancer Research Center of Hawaii
Honolulu, Hawaii, 96813, United States
Methodist Medical Center of Illinois
Peoria, Illinois, 61636, United States
Indiana University Cancer Center
Indianapolis, Indiana, 46202-5289, United States
Veterans Affairs Medical Center - Indianapolis (Roudebush)
Indianapolis, Indiana, 46202, United States
Cancer Center at Ball Memorial Hospital
Muncie, Indiana, 47303-3499, United States
Memorial Hospital of South Bend
South Bend, Indiana, 46601, United States
Union Hospital
Terre Haute, Indiana, 47804, United States
Wendt Regional Cancer Center at Finley Hospital
Dubuque, Iowa, 52001, United States
Esther Marie Hatton Cancer Care Center at St. Elizabeth Medical Center
Edgewood, Kentucky, 41017, United States
Tulane Cancer Center at Tulane University Hospital and Clinic
New Orleans, Louisiana, 70112-2699, United States
Greenebaum Cancer Center at University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
CCOP - Michigan Cancer Research Consortium
Ann Arbor, Michigan, 48106, United States
CCOP - Metro-Minnesota
Saint Louis Park, Minnesota, 55416, United States
CCOP - Kansas City
Kansas City, Missouri, 64131, United States
Methodist Hospital Cancer Center at Nebraska Methodist Hospital - Omaha
Omaha, Nebraska, 68114-4199, United States
Monmouth Medical Center
Long Branch, New Jersey, 07740-6395, United States
Atlantic City Medical Center - Mainland Division
Pomona, New Jersey, 08240, United States
Community Medical Center
Toms River, New Jersey, 08755, United States
SUNY Downstate Medical Center
Brooklyn, New York, 11203, United States
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
East Syracuse, New York, 13057, United States
Wayne Memorial Hospital, Incorporated
Goldsboro, North Carolina, 27533, United States
Akron General's McDowell Cancer Center
Akron, Ohio, 44302, United States
Akron City Hospital at Summa Health System
Akron, Ohio, 44304, United States
Adena Regional Medical Center
Chillicothe, Ohio, 45601, United States
Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University
Cleveland, Ohio, 44106-5065, United States
CCOP - Columbus
Columbus, Ohio, 43206, United States
Mount Carmel West Hospital
Columbus, Ohio, 43222, United States
CCOP - Dayton
Dayton, Ohio, 45429, United States
Grady Memorial Hospital
Delaware, Ohio, 43015, United States
Fairfield Medical Center
Lancaster, Ohio, 43130, United States
Strecker Cancer Center at Marietta Memorial Hospital
Marietta, Ohio, 45750-1635, United States
Licking Memorial Cancer Care Program at Licking Memorial Hospital
Newark, Ohio, 43055-2899, United States
CCOP - Toledo Community Hospital
Toledo, Ohio, 43623-3456, United States
CCOP - Columbia River Oncology Program
Portland, Oregon, 97225, United States
St. Luke's Hospital Cancer Center
Bethlehem, Pennsylvania, 18015, United States
Bryn Mawr Hospital
Bryn Mawr, Pennsylvania, 19010, United States
Delaware County Regional Cancer Center at Delaware County Memorial Hospital
Drexel Hill, Pennsylvania, 19026, United States
Dale and Frances Hughes Cancer Center at Pocono Medical Center
East Stroudsburg, Pennsylvania, 18301, United States
Cancer Center at Paoli Memorial Hospital
Paoli, Pennsylvania, 19301-1792, United States
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania, 19107-5541, United States
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212-4772, United States
Mercy Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15219, United States
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
Pittsburgh, Pennsylvania, 15224, United States
Reading Hospital and Medical Center
Reading, Pennsylvania, 19612-6052, United States
CCOP - MainLine Health
Wynnewood, Pennsylvania, 19096, United States
Lankenau Cancer Center at Lankenau Hospital
Wynnewood, Pennsylvania, 19096, United States
Cottonwood Hospital Medical Center
Murray, Utah, 84107, United States
McKay-Dee Hospital Center
Ogden, Utah, 84403, United States
Utah Valley Regional Medical Center - Provo
Provo, Utah, 84604, United States
University of Utah Health Sciences Center
Salt Lake City, Utah, 84132, United States
LDS Hospital
Salt Lake City, Utah, 84143, United States
Dixie Regional Medical Center
St. George, Utah, 84770, United States
CCOP - Marshfield Clinic Research Foundation
Marshfield, Wisconsin, 54449, United States
Community Memorial Hospital
Menomonee Falls, Wisconsin, 53051, United States
Medical College of Wisconsin Cancer Center
Milwaukee, Wisconsin, 53226, United States
Veterans Affairs Medical Center - Milwaukee (Zablocki)
Milwaukee, Wisconsin, 53295, United States
All Saints Cancer Center at All Saints Healthcare
Racine, Wisconsin, 53405, United States
Waukesha Memorial Hospital Regional Cancer Center
Waukesha, Wisconsin, 53188, United States
Related Publications (3)
Ajani JA, Winter K, Komaki R, Kelsen DP, Minsky BD, Liao Z, Bradley J, Fromm M, Hornback D, Willett CG. Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. J Clin Oncol. 2008 Oct 1;26(28):4551-6. doi: 10.1200/JCO.2008.16.6918. Epub 2008 Jun 23.
PMID: 18574157RESULTKomaki R, Winter K, Ajani J: Non-operative therapy of local-regional carcinoma of the esophagus: a randomized phase II study of two paclitaxel-based chemoradiotherapy regimens (RTOG 0113). [Abstract] The American Radium Society 89th Annual Meeting, May 5-29, 2007, Amsterdam, Netherlands. A-SS-2, 1, 2007.
RESULTKomaki R, Winter K, Ajani A, et al.: A randomized phase II study of two paclitaxel-based chemoradiotherapy regimens for patients with the non-operative esophageal carcinoma (RTOG 0113). [Abstract] Int J Radiat Oncol Biol Phys 66 (3 Suppl 1): A-142, S79-80, 2006.
RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jaffer A. Ajani, MD
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Purpose
- TREATMENT
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2001
First Posted
January 27, 2003
Study Start
April 1, 2001
Primary Completion
July 1, 2006
Last Updated
July 19, 2013
Record last verified: 2004-07